PTHrP is expressed in 60% of invasive breast tumors [15], suggesting that substantial proportion of hypercalcemia present in breast cancer patients with extensive bone metastasis, often recognized as LOH, is caused by multiple humoral factors including PTHrP, TNFα, and interleukins. This evidence concerns the gene PTHLH and Hypercalcemia.